The effects of 4-OXO-DHA on molecular targets that can account for cell growth inhibition The goal of the present study was to elucidate the molecular targets that can account for growth inhibition by 4-OXO-DHA (25 M, 72 h exposure) using breast cancer cells with different molecular subtypes [ER, PR, Her-2: + , + , + (BT-474)
Format & Handling Supplied in sterile laboratory glass vials containing lyophilized peptide material
Backbone: It is a 39amino acid peptide , structurally engineered from the native GIP sequence as its base scaffold
100% of the patients treated with 8 mg of the peptide experienced at least a 5% reduction in body weight, 91% had at least a 10% reduction, and 75% had at least a 15% reduction
Likely, your peptide prescription will also come with everything you need to do just that bacteriostatic water and needle syringes
Both dissolve the lyophilized powder just fine